XML 13 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Balance Sheets (Unaudited) - USD ($)
Sep. 30, 2017
Dec. 31, 2016
Current assets    
Cash and cash equivalents $ 304,597 $ 314,520
Accounts receivable 1,083,137 774,275
Inventories 1,788,784 1,476,240
Prepaids and other current assets 609,414 736,447
Total current assets 3,785,932 3,301,482
Long-term assets    
Restricted bank and money market accounts 952,536 450,631
Property, plant and equipment, net 1,904,103 1,948,076
Investment 0 1,492,781
Patents and other intangibles, net 5,923,738 4,186,295
Total long-term assets 8,780,377 8,077,783
Total assets 12,566,309 11,379,265
Current liabilities    
Accounts payable 2,000,966 941,659
Accrued liabilities 714,014 568,714
Convertible debt, net of debt discount 0 3,025,165
Current portion of unearned revenue 2,952,658 2,608,328
Current installments of notes payable 67,313 366,953
Total current liabilities 5,734,951 7,510,819
Long-term liabilities    
Obligation for lease disposal costs 476,044 468,974
Unearned revenues, net of current portion 364,440 364,440
Notes payable, net of current portion and debt discount 443,476 428,891
Mandatorily redeemable convertible preferred stock 4,496,334 850,000
Total long-term liabilities 5,780,294 2,112,305
Total liabilities 11,515,245 9,623,124
Stockholders' Equity    
Common stock 4,067,554 4,049,998
Additional paid-in capital 120,355,848 119,595,535
Accumulated deficit (124,910,190) (121,939,561)
(Deficit) Equity attributable to International Isotopes Inc. stockholders (486,788) 1,705,972
Equity attributable to noncontrolling interest 1,537,852 50,169
Total equity 1,051,064 1,756,141
Total liabilities and stockholders' equity $ 12,566,309 $ 11,379,265